Trials / Recruiting
RecruitingNCT05879913
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
Personalized Medical Treatment of Coronary Atherosclerosis in Prostate Cancer Patients Guided by Plaque Assessment With Quantitative Coronary CT Angiography (CCTA)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Indiana University · Academic / Other
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized pilot study of Coronary CT Angiography (CCTA) for coronary atherosclerosis vs. Usual Care in patients with prostate cancer who are either planning to begin, or are currently taking androgen deprivation therapy (ADT) .
Detailed description
This is a randomized pilot study where subjects are randomized 1:1 to either the CCTA group or non-CCTA (usual care) group. The target enrollment will be 100 subjects with accounting for a potential 10% dropout rate resulting in an sample size between 90-100 participants or 45-50per group arm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Coronary CT Angiography (CCTA) | Coronary computed tomographic angiography (CCTA) scan is a highly accurate noninvasive technique for detection of coronary artery plaque. |
Timeline
- Start date
- 2023-12-15
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2023-05-30
- Last updated
- 2026-02-25
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05879913. Inclusion in this directory is not an endorsement.